Oral vs. Injectable GLP-1s: How Daily Pills Compare to Weekly Injections
Written by Dan Cripe, RN, BSN & Marcia Cripe, RN | Last Updated: September 21, 2026
Medical Note
This article is
Trulicity: Weekly Dulaglutide
Written by Dan Cripe, RN, BSN & Marcia Cripe, RN | Last Updated: September 21, 2026
Medical Note
This article is
Victoza: Daily Liraglutide for Type 2 Diabetes
Written by Dan Cripe, RN, BSN & Marcia Cripe, RN | Last Updated: September 20, 2026
Medical Note
This article is
Saxenda: Daily Liraglutide for Weight Management
Written by Dan Cripe, RN, BSN & Marcia Cripe, RN | Last Updated: September 20, 2026
Medical Note
This article is
Older GLP-1 Agonists: Saxenda, Victoza, and Trulicity in the Modern Era
Written by Dan Cripe, RN, BSN & Marcia Cripe, RN | Last Updated: September 19, 2026
Medical Note
This article is
Retatrutide and the Future of Triple Agonists (GLP-1, GIP, Glucagon)
Written by Dan Cripe, RN, BSN & Marcia Cripe, RN | Last Updated: September 19, 2026
Medical Note
This article is
GLP-1 Non-Responders: Why Ozempic or Mounjaro Doesn’t Work for Everyone (and What to Do Next)
Written by Dan Cripe, RN, BSN & Marcia Cripe, RN | Last Updated: September 18, 2026
Medical Note
This article is
Zepbound: Tirzepatide for Chronic Weight Management
Written by Dan Cripe, RN, BSN & Marcia Cripe, RN | Last Updated: September 18, 2026
If you're considering
Mounjaro vs. Zepbound: Comparing Tirzepatide Brands and Approvals
Written by Dan Cripe, RN, BSN & Marcia Cripe, RN | Last Updated: September 17, 2026
Medical Note
This article is
Mounjaro: Tirzepatide for Type 2 Diabetes
Written by Dan Cripe, RN, BSN & Marcia Cripe, RN | Last Updated: September 17, 2026
Medical Note
This article is